Evidence map›Paper›PMID 29371132›Full record

ReviewActa biomaterialia2018

Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues.

Rajeev J Kant, Kareen L K Coulombe

Abstract readReview
In one paragraph

Review in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Bioprinting Technologies and Bioinks for Vascular Model Establishment.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
  16. Engineering Spatiotemporal Control in Vascularized Tissues.Bioengineering (Basel, Switzerland) · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rajeev J KantCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, RI, USA.
Kareen L K CoulombeCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, RI, USA. Electronic address: kareen_coulombe@brown.edu.

Funding

Engineering Human Myocardium with Hybrid Biomaterials for Heart Regeneration - SUPPR01HL135091 · NHLBI · BROWN UNIVERSITY · PI COULOMBE, KAREEN LK · 2017 to 2021
$2.6M
Regenerating the Heart with Engineered Human Cardiac TissueR00HL115123 · NHLBI · BROWN UNIVERSITY · PI COULOMBE, KAREEN LK · 2014 to 2016
$747k
Regenerating the Heart with Engineered Human Cardiac TissueK99HL115123 · NHLBI · UNIVERSITY OF WASHINGTON · PI COULOMBE, KAREEN LK · 2012 to 2013
$144k
NHLBI NIH HHS R00 HL115123NHLBI NIH HHS R01 HL135091
6 · The paper itself

Abstract

The field of tissue engineering has turned towards biomimicry to solve the problem of tissue oxygenation and nutrient/waste exchange through the development of vasculature. Induction of angiogenesis and subsequent development of a vascular bed in engineered tissues is actively being pursued through combinations of physical and chemical cues, notably through the presentation of topographies and growth factors. Presenting angiogenic signals in a spatiotemporal fashion is beginning to generate improved vascular networks, which will allow for the creation of large and dense engineered tissues. This review provides a brief background on the cells, mechanisms, and molecules driving vascular development (including angiogenesis), followed by how biomaterials and growth factors can be used to direct vessel formation and maturation. Techniques to accomplish spatiotemporal control of vascularization include incorporation or encapsulation of growth factors, topographical engineering, and 3D bioprinting. The vascularization of engineered tissues and their application in angiogenic therapy in vivo is reviewed herein with an emphasis on the most densely vascularized tissue of the human body - the heart. STATEMENT OF SIGNIFICANCE: Vascularization is vital to wound healing and tissue regeneration, and development of hierarchical networks enables efficient nutrient transfer. In tissue engineering, vascularization is necessary to support physiologically dense engineered tissues, and thus the field seeks to induce vascular formation using biomaterials and chemical signals to provide appropriate, pro-angiogenic signals for cells. This review critically examines the materials and techniques used to generate scaffolds with spatiotemporal cues to direct vascularization in engineered and host tissues in vitro and in vivo. Assessment of the field's progress is intended to inspire vascular applications across all forms of tissue engineering with a specific focus on highlighting the nuances of cardiac tissue engineering for the greater regenerative medicine community.

Indexed as

BioprosthesisBlood Vessel ProsthesisNeovascularization, PhysiologicPrinting, Three-DimensionalAngiogenesis Inducing AgentsAnimalsBioprintingHumansTissue EngineeringAngiogenesis Inducing AgentsAngiogenesisBiomaterialsCardiac tissueGrowth factorsTissue engineeringVascularization

Identifiers

PMID29371132
PMCPMC5831518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.